Pamela Kunz: Honored to serve as Editor-in-Chief for JCO Oncology Advances
Pamela Kunz shared a post by ASCO on X:
“I honored to serve as Editor-in-Chief for JCO Oncology Advances! To learn more, please read my editorial.”
Quoting ASCO’S post:
“Announcing JCO Oncology Advances! A NEW open-access journal featuring groundbreaking breast & GI cancer research. Read the 1st issue now.”
Source: Pamela Kunz/X and ASCO/X
Pamela Kunz is an Associate Professor of Medicine in the Division of Oncology at Yale School of Medicine, Director of the Center for Gastrointestinal Cancers at Yale Cancer Center and Smilow Cancer Hospital. She was formerly the director of the Stanford Neuroendocrine Tumor Program, Leader of the Endocrine Oncology Research Group, and Director of the Neuroendocrine Tumor Fellowship.
Dr. Kunz is the President of the North American Neuroendocrine Tumor Society (NANETS) and Chair of the Neuroendocrine Tumor Taskforce of the NCI. In addition, she has emerged as a leading voice for promoting gender equity in the medical workforce and has been appointed as the Vice Chief for DEI for the Section of Medical Oncology at Yale.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023